CN Patent

CN107573348B — 巴瑞克替尼三氟乙酸盐b晶型及其制备方法

Assigned to Shanghai Zhenyi Biotechnology Co ltd · Expires 2019-09-03 · 7y expired

What this patent protects

本发明提供了式(I)的巴瑞克替尼三氟乙酸盐的B晶型, 其中B晶型的XRPD图谱在2θ=5.34,9.00,10.08,10.70,16.12,17.44,17.80,18.92,19.48,20.22,21.56,22.68,23.42,23.98,25.84,27.22,28.76,29.46,32.66处有衍射峰,其中2θ值误差范围为±0.2。本发明的巴瑞克替尼三氟乙酸盐B晶型稳定性优于巴瑞克替尼三氟乙酸盐半晶体,有利于其药物加工和在药物组合物中的使用。巴瑞克替尼三氟乙酸盐B晶型可以在治疗自身免疫疾病、炎性疾病或癌症的药物中应用,同时提供的定性定量信…

USPTO Abstract

本发明提供了式(I)的巴瑞克替尼三氟乙酸盐的B晶型, 其中B晶型的XRPD图谱在2θ=5.34,9.00,10.08,10.70,16.12,17.44,17.80,18.92,19.48,20.22,21.56,22.68,23.42,23.98,25.84,27.22,28.76,29.46,32.66处有衍射峰,其中2θ值误差范围为±0.2。本发明的巴瑞克替尼三氟乙酸盐B晶型稳定性优于巴瑞克替尼三氟乙酸盐半晶体,有利于其药物加工和在药物组合物中的使用。巴瑞克替尼三氟乙酸盐B晶型可以在治疗自身免疫疾病、炎性疾病或癌症的药物中应用,同时提供的定性定量信息,对进一步研究此类固体药物的疗效具有重要的意义。

Drugs covered by this patent

Patent Metadata

Patent number
CN107573348B
Jurisdiction
CN
Classification
Expires
2019-09-03
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Zhenyi Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.